BV6 IAP Antagonist: Precision Apoptosis and Radiosensitiz...
2025-10-18
BV6, a selective IAP antagonist and Smac mimetic, empowers researchers to induce apoptosis and enhance therapy sensitivity in cancer and endometriosis models. This guide delivers actionable workflows, advanced applications, and troubleshooting strategies, maximizing the translational impact of BV6 in dissecting cancer cell survival pathways.